Earnings calendar/ANTX
AN2 Therapeutics, Inc. (ANTX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.20
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.27
Beat rate last 4: 25%
Latest EPS YoY
+14.3%
vs 2025-08-12
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 11, 2026
EPS beat
EPS actual / est
$-0.18 / $-0.24
+25.0%
Revenue actual / est
— / —
—
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.20 | Pending | — | — | Pending | — |
| 8/11/2026 | $-0.24 | $-0.18 | +25.0% | — | Pending | — |
| 5/12/2026upcoming | $-0.23 | Pending | — | — | Pending | — |
| 5/11/2026 | $-0.23 | $-0.29 | -26.1% | — | Pending | — |
| 3/24/2026upcoming | $-0.24 | Pending | — | — | Pending | — |
| 3/17/2026 | $-0.24 | $-0.29 | -20.8% | — | Pending | — |
| 11/12/2025 | $-0.23 | $-0.31 | -34.8% | — | Pending | — |
| 8/12/2025 | $-0.31 | $-0.21 | +32.3% | — | Pending | — |
| 5/13/2025 | $-0.26 | $-0.35 | -34.6% | — | Pending | — |
| 3/25/2025 | $-0.25 | $-0.25 | 0.0% | — | Pending | — |
| 11/13/2024 | $-0.37 | $-0.43 | -16.2% | — | Pending | — |
| 8/13/2024 | $-0.63 | $-0.48 | +23.8% | — | Pending | — |
| 5/14/2024 | $-0.61 | $-0.56 | +8.2% | — | Pending | — |
| 3/28/2024 | $-0.71 | $-0.57 | +19.7% | — | $80,000 | — |
| 11/9/2023 | $-0.63 | $-0.65 | -3.2% | — | Pending | — |
| 8/10/2023 | $-0.85 | $-0.81 | +4.7% | — | Pending | — |
| 5/11/2023 | $-0.68 | $-0.79 | -16.2% | — | Pending | — |
| 3/29/2023 | $-0.63 | $-0.61 | +3.2% | — | Pending | — |
| 11/9/2022 | $-0.59 | $-0.59 | 0.0% | — | Pending | — |
| 8/11/2022 | $-0.45 | $-0.53 | -17.8% | — | Pending | — |
| 5/10/2022 | $-0.52 | $-2.98 | -473.1% | — | Pending | — |
| 3/28/2022 | — | $-0.49 | — | — | Pending | — |
| 12/31/2021 | — | $-0.42 | — | — | Pending | — |
| 6/30/2021 | — | $-0.36 | — | — | Pending | — |
| 3/31/2021 | — | $-0.15 | — | — | Pending | — |
Need ANTX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.